Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease

被引:56
作者
Yasuoka, H
Okazaki, Y
Kawakami, Y
Hirakata, M
Inoko, H
Ikeda, Y
Kuwana, M
机构
[1] Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo 1608582, Japan
[2] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 11期
关键词
D O I
10.1002/art.20597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To detect and characterize the autoreactive CD8+ T cells to major histocompatibility complex class I chain-related gene A (MICA), a stress-inducible antigen preferentially expressed on the epithelium and endothelium, in patients with Behcet's disease (BD). Methods. A candidate for the antigenic MICA peptide was selected based on its predicted binding affinity for HLA-B51 and proteasomal cleavage sites. Peripheral blood T cells from 14 patients with BD and 15 healthy controls were repeatedly stimulated with the MICA peptide, and the specific T cell response was measured by peptide-induced interferon-gamma. Cytotoxic T lymphocyte activity was examined by chromium-51 release from an HLA-B51-transfected B cell line in the presence of the MICA peptide. Results. A 9-mer peptide AAAAAIFVI (termed MICA transmembrane [MICA-TM]) was selected as a candidate for the antigenic peptide presented by HLA-B51. A specific T cell response to MICA-TM was detected in 4 patients with BD (29%) but in none of the 15 healthy donors. All 4 responders had HLA-B51 and active disease, and the specific T cell response was lost after the BD-related symptoms disappeared. The MICA-induced T cell response was specifically inhibited by anti-HILA class I antibody or by CD8+ cell depletion. MICA-reactive T cells recognized an HLA-B51-transfected B cell line pulsed with MICA-TM or a B cell line transfected with both HLA-B51 and MICA in the absence of exogenous peptides. Finally, MICA-stimulated T cell lines lysed the HLA-B51-expressing B cell line in the presence of MICA-TM. Conclusion. HLA-B51-restricted cytotoxic T lymphocytes autoreactive to MICA may be involved in the pathogenesis of BD.
引用
收藏
页码:3658 / 3662
页数:5
相关论文
共 15 条
[1]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[2]   Behet's disease: infectious aetiology, new autoantigens, and HLA-B51 [J].
Direskeneli, H .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (11) :996-1002
[3]   Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells [J].
Groh, V ;
Steinle, A ;
Bauer, S ;
Spies, T .
SCIENCE, 1998, 279 (5357) :1737-1740
[4]   Identification of HLA-A2-restricted CD8+ cytotoxic T cell responses in primary biliary cirrhosis:: T cell activation is augmented by immune complexes cross-presented by dendritic cells [J].
Kita, H ;
Lian, ZX ;
Van de Water, J ;
He, XS ;
Matsumura, S ;
Kaplan, M ;
Luketic, V ;
Coppel, RL ;
Ansari, AA ;
Gershwin, ME .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :113-123
[5]  
Lehner T, 1997, Int Rev Immunol, V14, P21, DOI 10.3109/08830189709116842
[6]   Autoreactive CD8 T cells in organ-specific autoimmunity: Emerging targets for therapeutic intervention [J].
Liblau, RS ;
Wong, FS ;
Mars, LT ;
Santamaria, P .
IMMUNITY, 2002, 17 (01) :1-6
[7]   BEHCETS-DISEASE ASSOCIATED WITH ONE OF THE HLA-B51 SUBANTIGENS, HLA-B-ASTERISK 5101 [J].
MIZUKI, N ;
INOKO, H ;
ANDO, H ;
NAKAMURA, S ;
KASHIWASE, K ;
AKAZA, T ;
FUJINO, Y ;
MASUDA, K ;
TAKIGUCHI, M ;
OHNO, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 116 (04) :406-409
[8]  
Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298
[9]   A strong association between HLA-B*5101 and Behcet's disease in Greek patients [J].
Mizuki, N ;
Ohno, S ;
Ando, H ;
Chen, L ;
Palimeris, GD ;
StavropoulosGhiokas, E ;
Ishihara, M ;
Goto, K ;
Nakamura, S ;
Shindo, Y ;
Isobe, K ;
Ito, N ;
Inoko, H .
TISSUE ANTIGENS, 1997, 50 (01) :57-60
[10]  
RIVOLTINI L, 1995, J IMMUNOL, V154, P2257